Abingworth
Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PCVX, VRNA, VERA, HLVX, ACET, and represent 87.31% of Abingworth's stock portfolio.
- Reduced shares in these 1 stock: PCVX (-$103M).
- Abingworth was a net seller of stock by $-103M.
- Abingworth has $307M in assets under management (AUM), dropping by 4.94%.
- Central Index Key (CIK): 0001397144
Tip: Access up to 7 years of quarterly data
Positions held by Abingworth consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Abingworth
Abingworth holds 19 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 31.5 | $97M | -51% | 2.0M | 47.95 |
|
| Verona Pharma Sponsored Ads (VRNA) | 20.9 | $64M | 2.5M | 26.13 |
|
|
| Vera Therapeutics Cl A (VERA) | 18.7 | $57M | 3.0M | 19.35 |
|
|
| Hillevax (HLVX) | 10.0 | $31M | 1.8M | 16.73 |
|
|
| Adicet Bio (ACET) | 6.2 | $19M | 2.1M | 8.94 |
|
|
| Phathom Pharmaceuticals (PHAT) | 5.2 | $16M | 1.4M | 11.22 |
|
|
| Reneo Pharmaceuticals (RPHM) | 1.6 | $4.8M | 2.1M | 2.33 |
|
|
| Sientra | 1.1 | $3.4M | 1.7M | 2.03 |
|
|
| Jasper Therapeutics | 0.9 | $2.7M | 5.6M | 0.48 |
|
|
| Soleno Therapeutics (SLNO) | 0.8 | $2.4M | 1.2M | 1.98 |
|
|
| Nucana Sponsored Adr | 0.7 | $2.2M | 3.3M | 0.66 |
|
|
| Effector Therapeutics | 0.7 | $2.1M | 4.8M | 0.43 |
|
|
| Spruce Biosciences (SPRB) | 0.6 | $2.0M | 1.8M | 1.10 |
|
|
| Paratek Pharmaceuticals | 0.6 | $1.9M | 1.0M | 1.87 |
|
|
| Cymabay Therapeutics | 0.3 | $822k | 131k | 6.27 |
|
|
| Exicure Com New (XCUR) | 0.1 | $324k | 282k | 1.15 |
|
|
| Aeglea Biotherapeutics | 0.0 | $108k | 241k | 0.45 |
|
|
| Molecular Templates | 0.0 | $66k | 200k | 0.33 |
|
|
| Obseva Sa | 0.0 | $13k | 88k | 0.14 |
|
Past Filings by Abingworth
SEC 13F filings are viewable for Abingworth going back to 2010
- Abingworth 2022 Q4 filed Feb. 10, 2023
- Abingworth 2022 Q3 filed Nov. 10, 2022
- Abingworth 2022 Q2 filed Aug. 15, 2022
- Abingworth 2022 Q1 filed May 16, 2022
- Abingworth 2021 Q4 filed Feb. 16, 2022
- Abingworth 2021 Q3 filed Nov. 15, 2021
- Abingworth 2021 Q2 filed Aug. 16, 2021
- Abingworth 2021 Q1 filed May 17, 2021
- Abingworth 2020 Q4 filed March 1, 2021
- Abingworth 2020 Q3 filed Nov. 16, 2020
- Abingworth 2020 Q2 filed Aug. 14, 2020
- Abingworth 2020 Q1 filed May 14, 2020
- Abingworth 2019 Q4 filed Feb. 14, 2020
- Abingworth 2019 Q3 filed Nov. 14, 2019
- Abingworth 2019 Q2 filed Aug. 14, 2019
- Abingworth 2019 Q1 filed May 15, 2019